title: Modified ASRA facilitates the characterization of activating point mutations in tumors, in which cancer cells constitute only a minor part of the investigated tissue.
authors.affiliation: Institute of Toxicology, University of Würzburg, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Papp
authors.forename: M
authors.initials: M
authors.lastname: Jafari
authors.forename: U
authors.initials: U
authors.lastname: Diener
authors.forename: N
authors.initials: N
authors.lastname: Dudley
authors.forename: D
authors.initials: D
authors.lastname: Schiffmann
mesh_terms: D001483:Base Sequence; D017931:DNA Primers; D015972:Gene Expression Regulation, Neoplastic; D011905:Genes, ras; D006801:Humans; D007202:Indicators and Reagents; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000235:genetics*; D016376:Oligonucleotides, Antisense; D017354:Point Mutation; D016133:Polymerase Chain Reaction / Q000379:methods*
chemical_list: D017931:DNA Primers; D007202:Indicators and Reagents; D016376:Oligonucleotides, Antisense